Evidence map›Paper›PMID 19890664›Full record

ArticleHuman genetics2010

Common CFTR gene variants influence body composition and survival in rural Ghana.

Maris Kuningas, David van Bodegom, Linda May, Johannes J Meij, P Eline Slagboom, Rudi G J Westendorp

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maris KuningasDepartment of Gerontology and Geriatrics, Leiden University Medical Center (LUMC), C2-R, PO Box 9600, 2300 RC Leiden, The Netherlands. M.Kuningas@lumc.nl
David van Bodegom
Linda May
Johannes J Meij
P Eline Slagboom
Rudi G J Westendorp
Leiden University Medical Center · NLLeyden Academy on Vitality and Ageing · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various studies in mice have found support for the hypothesis that heterozygous carriers of cystic fibrosis transmembrane conductance regulator (CFTR) mutations have an increased resistance to fatal infection compared to both homozygous mutation carriers and non-carriers, while in humans such evidence is scarce. In this study, we assessed the CFTR heterozygotes survival advantage hypothesis in a contemporary rural population that lives under adverse environmental conditions in the Upper-East region of Ghana. We genotyped 30 SNPs throughout the CFTR gene in 4,230 participants and tested their influence on survival and on body composition in the population at large. With a sliding-window haplotype analysis, we identified a set of six common haplotypes that influenced survival probabilities (global p = 6.00 x 10(-05)). Individual haplotype analyses revealed two haplotypes of specific interest. One of these haplotypes was enriched (p = 0.003), whereas the other was depleted (p = 0.041) among people of old age (> or = 65 years) compared to young study participants (< or = 5 years). In addition, children (n = 474) carrying the latter haplotype had lower body weight (p (trend) = 0.020) and height (p (trend) = 0.010) compared to non-carriers. For all these analyses, similar associations for heterozygous and homozygous CFTR haplotype carriers were observed, revealing an additive effect of haplotype alleles. In conclusion, we identified common haplotypes in the CFTR gene that influence survival and body composition in the population at large with no evidence for heterozygote advantage.

Indexed as

Polymorphism, Single NucleotideAdolescentAdultAgedBody CompositionChildChild, PreschoolCystic Fibrosis Transmembrane Conductance RegulatorFemaleGene FrequencyGenetic VariationGenotypeGhanaHaplotypesHumansInfantCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID19890664
PMCPMC2806536
OpenAlexW2109437658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.